PRESS RELEASE published on 11/25/2024 at 17:45, 1 year 10 months ago Lutte contre le mildiou en vigne : Des essais montrent l'efficacité du produit de biocontrôle AXPERA sur le mildiou de la vigne dans des conditions difficiles en 2024 Amoéba annonce le succès de son essai sur le mildiou de la vigne avec son nouveau biofongicide AXPERA en partenariat avec IFV+, offrant une solution durable aux viticulteurs français AMOEBA Viticulture AXPERA Biofongicide Mildiou
PRESS RELEASE published on 11/25/2024 at 17:45, 1 year 10 months ago Combating downy mildew in vines: Trials show the effectiveness of the biocontrol product AXPERA on downy mildew in vines under difficult conditions in 2024 Amoéba and IFV+ successfully tested AXPERA, a new amoeba lysate-based biofungicide, against downy mildew in vines in south-west France. AXPERA shows promising effectiveness in reducing fungal disease symptoms AMOEBA Biofungicide AXPERA IFV+ Downy Mildew
BRIEF published on 11/21/2024 at 17:50, 1 year 10 months ago Amoéba publie un article sur son innovation cosmétique AMOEBA Innovation Cosmétique Lysat De Willaertia Vieillissement Cutané
BRIEF published on 11/21/2024 at 17:50, 1 year 10 months ago Amoéba publishes an article on its cosmetic innovation AMOEBA Innovation Cosmetic Willaertia Lysate Skin Aging
PRESS RELEASE published on 11/21/2024 at 17:45, 1 year 10 months ago Amoéba annonce la publication d'un premier article scientifique sur l'efficacité de son innovation en cosmétique Amoéba, greentech française, publie un article scientifique sur l'efficacité de son lysat de Willaertia dans le journal Cosmetics. Les données montrent une amélioration de la cicatrisation, de la pigmentation et une réduction des signes du vieillissement cutané AMOEBA Cosmétique GreenTech Lysat De Willaertia Vieillissement Cutané
PRESS RELEASE published on 11/21/2024 at 17:45, 1 year 10 months ago Amoéba announces the publication of a first scientific article on the efficacy of its innovation in cosmetics Amoéba announces publication of a scientific article on the efficacy of Willaertia lysate in Cosmetics journal. Discover the natural microbiological solution's benefits for skin anti-aging AMOEBA Willaertia Lysate Cosmetics Journal Skin Anti-aging Microbiological Solution
BRIEF published on 10/07/2024 at 17:50, 1 year 11 months ago Amoéba Publie son Rapport Financier Semestriel au 30 Juin 2024 AMOEBA Biocontrôle Cosmétique Rapport Financier Investisseurs
BRIEF published on 10/07/2024 at 17:50, 1 year 11 months ago Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024 AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE published on 10/07/2024 at 17:45, 1 year 11 months ago Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2024 Amoéba, société greentech basée à Chassieu, publie son rapport financier semestriel au 30 juin 2024 et annonce un prochain séminaire Biotech & Santé. En savoir plus sur amoeba-nature.com AMOEBA Biotech Rapport Financier GreenTech Séminaire
PRESS RELEASE published on 10/07/2024 at 17:45, 1 year 11 months ago Amoéba: Publication of the half-year financial report at 30 June 2024 Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
Published on 09/29/2026 at 02:30, 25 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 2 hours 55 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 3 hours 55 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/28/2026 at 15:00, 11 hours 55 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 12 hours 10 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 22:14, 4 hours 41 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 19:24, 7 hours 30 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 09/28/2026 at 19:00, 7 hours 55 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026
Published on 09/28/2026 at 18:00, 8 hours 55 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 8 hours 55 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:54, 9 hours ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 9 hours ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 9 hours 10 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 9 hours 20 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026